Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. - Wikidata - wikimedia - TriplyDB

Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients.

Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients.

http://www.wikidata.org/entity/Q33716613

about

Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials Development of a vaccine against Staphylococcus aureus Neutrophil-Mediated Phagocytosis of Staphylococcus aureus Neutrophil recruitment to lymph nodes limits local humoral response to Staphylococcus aureus Rhesus macaques (Macaca mulatta) are natural hosts of specific Staphylococcus aureus lineages Staphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach?Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection.Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans Sequence diversity in the A domain of Staphylococcus aureus fibronectin-binding protein A Proteomics-based identification of anchorless cell wall proteins as vaccine candidates against Staphylococcus aureus An Update on Clinical Burden, Diagnostic Tools, and Therapeutic Options of Staphylococcus aureus Identifying functional anti-Staphylococcus aureus antibodies by sequencing antibody repertoires of patient plasmablasts.Levels of antibody against 11 Staphylococcus aureus antigens in a healthy population.Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo Four-component Staphylococcus aureus vaccine 4C-staph enhances Fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice.Functional antibodies targeting IsaA of Staphylococcus aureus augment host immune response and open new perspectives for antibacterial therapy.Immunization with Staphylococcus aureus clumping factor B, a major determinant in nasal carriage, reduces nasal colonization in a murine model.Staphylococcus aureus infection induces protein A-mediated immune evasion in humans.Characterization of the humoral immune response during Staphylococcus aureus bacteremia and global gene expression by Staphylococcus aureus in human blood.Staphylococcus aureus seroproteomes discriminate ruminant isolates causing mild or severe mastitis Protective activity of the CnaBE3 domain conserved among Staphylococcus aureus Sdr proteins.Protein A suppresses immune responses during Staphylococcus aureus bloodstream infection in guinea pigs.Active immunization with an octa-valent Staphylococcus aureus antigen mixture in models of S. aureus bacteremia and skin infection in mice Vaccine assembly from surface proteins of Staphylococcus aureus.Exfoliative toxins of Staphylococcus aureus Proteomic analyses of host and pathogen responses during bovine mastitis.Immunoproteomic Identification of In Vivo-Produced Propionibacterium acnes Proteins in a Rabbit Biofilm Infection Model Mild Staphylococcus aureus Skin Infection Improves the Course of Subsequent Endogenous S. aureus Bacteremia in Mice Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity Attenuation of Staphylococcus aureus-Induced Bacteremia by Human Mini-Antibodies Targeting the Complement Inhibitory Protein Efb Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection.Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.A Diagnostic Serum Antibody Test for Patients With Staphylococcus aureus Osteomyelitis.Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model Recurrent infections and immune evasion strategies of Staphylococcus aureus.Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections.Role of protein A in the evasion of host adaptive immune responses by Staphylococcus aureus.Serologic assay to quantify human immunoglobulin G antibodies to the Staphylococcus aureus iron surface determinant B antigen.Anti-glucosaminidase IgG in sera as a biomarker of host immunity against Staphylococcus aureus in orthopaedic surgery patients

P2860

Q21131308-415D3FC2-918B-4213-B9B1-6C440CA6F738 Q27015365-426246A1-4BD7-4063-8C75-77C2DF3B887C Q27025128-477890D7-586F-4A6A-A5C3-337EAE668E61 Q27320235-D63C09D1-C215-4A2A-B867-43D70C7B2366 Q28743667-50C01254-878E-4795-B891-17EC03444EBB Q30239977-51B8F759-8C0E-4B37-9FEE-E42BF10AE3F0 Q33244198-9E089211-CCD4-4996-A4DE-F8240B78CFFF Q33315030-5BC4E62B-61D0-40AA-91C4-F1260120FCA5 Q33333126-1B49EB35-F0FA-4B5B-9A81-E53578A0CB6D Q33429774-F31EE443-4299-4BB4-906D-1425925F9CD6 Q33723258-3DCB4287-D0C4-4DD5-B8C3-601D225F130D Q33788094-DBAFB142-137D-4A8A-8933-7B98C6A87A1C Q33962714-6E3C073E-5EC1-4106-BD94-F58D44B215B1 Q34352027-E9948B2D-1050-44A3-A637-86F17B5F956F Q34478033-713215BD-58CA-4EA7-AA7E-71BF177C5C58 Q34483544-514512CC-14A9-4B68-B2A8-8704534467F6 Q34492747-1D2B5D4D-1990-4625-8F0A-CEBB5FC89D98 Q34533083-060958C5-A551-4006-ACEE-BC733669424E Q34545013-5184503F-7982-4A47-895D-9622D4EAB74A Q34639298-71B2D52E-666F-46B1-9AF8-5B43A213C5E3 Q34999275-1090782B-F35B-47AB-982E-D70446FC5CE8 Q35038206-96C9C61D-68E7-457F-8FE8-14CE0DAA25B7 Q35116935-6785733E-84AB-40B4-AD69-A0363DFC127A Q35130822-4D6D4ACA-E8A2-4BC6-B804-363157D93080 Q35155819-5DC5ED9A-F08E-4DF9-B9AA-75216D5F79A2 Q35529379-124FF2F9-1FF8-4DF1-8A95-25E0471E89F0 Q35548040-27714462-FDB9-458B-9816-E2430A576AFC Q35659395-CBA304F6-4A7B-44BE-9587-D98C516E6D82 Q35762600-D6C96E0F-6D04-4BCD-8663-B7615DD80605 Q35765208-C8D321FF-BD16-4D41-8E2F-1C129B466606 Q35833250-F4B76BDC-1F96-487A-822C-13C4DF589817 Q35880109-27F0ABC1-6C5D-4A1F-82D1-7D1B00C7D1EC Q35912386-55896761-18B3-4AD5-8C65-12221584AB8F Q36184397-AF2C7DDF-93ED-41B5-8FF9-0F26BD742D52 Q36513761-ABB8CDB2-D7C4-48FA-B94D-4C2754FC812E Q36569841-0A547D85-EDDB-4AE3-A5D5-FBE3D4B59FD9 Q36609408-26EA264B-ADDB-4D9D-868C-0A8E554C65A8 Q37140096-51BA7F35-778A-4D84-810D-C6D8F746C296 Q37190930-04D05DB8-B00E-4C1D-A2B3-3DA62257F12C Q37290020-E161490A-349F-471A-9268-9000D917CF7D

P2860

Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients.

http://www.wikidata.org/entity/Q33716613

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Comparison of antibody reperto ...... in acutely infected patients.

@ast

Comparison of antibody reperto ...... in acutely infected patients.

@en

type

label

Comparison of antibody reperto ...... in acutely infected patients.

@ast

Comparison of antibody reperto ...... in acutely infected patients.

@en

prefLabel

Comparison of antibody reperto ...... in acutely infected patients.

@ast

Comparison of antibody reperto ...... in acutely infected patients.

@en

P1433

Q33716613-A266DA40-4653-4775-B83B-C191CD70990A

P1476

Q33716613-60127C9B-47DA-4625-9BC6-72FA7E7DC875

P2093

Q33716613-15B95742-3312-4188-8C47-E3370B51A9FB

Q33716613-2C7F5D4D-864D-4E96-BB0F-6A4ACF92ADBA

Q33716613-2CC4A7A5-72A8-4A6C-B0F7-447704FF24EB

Q33716613-311665A1-2735-435C-9B3E-63B867FD97B7

Q33716613-311E0F28-D188-4250-A7D6-1387B2E6490B

Q33716613-3DD06560-812E-44D3-960B-BC1968ACA10E

Q33716613-7B967337-1311-4EF5-8D79-143F140E0BC6

Q33716613-9001F365-7561-443E-A42A-254A3ED45FD5

Q33716613-A6FA6EA6-4D76-4E96-B4C7-18AA1BF99908

Q33716613-E28B5C7D-B4D8-4A90-8436-08A71ABD2A06

P2860

Q33716613-060BC29B-0C86-49E3-B574-46354B1247A3

Q33716613-09B91B67-2C58-45E4-9514-C30081B16F60

Q33716613-16C39F7C-96E4-4D08-9AF2-201CCCFEFF9C

Q33716613-1C421B39-CAA5-43A0-B1CF-49814CFFCFF9

Q33716613-1D0A926A-0739-4E20-9852-D561E38D5864

Q33716613-20717034-D30C-42ED-8FDA-6662F769E31C

Q33716613-25506CC8-4CCF-47F4-B91F-EADBBA587343

Q33716613-2FDB7C75-922E-49A1-97F4-EEBD998AC40A

Q33716613-3A186186-51C6-4DAD-8ED0-B646008D451C

Q33716613-3C5148E2-C608-41FA-9F4E-9AA13A4B27F8

P304

Q33716613-F29284FD-66DA-4241-9234-4C5809DB0562

P31

Q33716613-08F9816D-9C43-420A-93E2-DA6520605088

P356

Q33716613-53897D7B-E6C3-48E6-82E8-34C95686163A

P433

Q33716613-CBC02EF1-472C-4727-ADD7-D6DA032A3533

P478

Q33716613-12FCF6FE-4241-45DA-A4BA-C69B75865467

P577

Q33716613-0CA0E582-9B99-458E-AAD3-7E175F5C801B

P698

Q33716613-44BA11B2-A822-40CE-8A1E-40987048B9A4

P921

Q33716613-C96A449A-384E-4DF1-BC1E-9F31FA12F787

P932

Q33716613-DF0F4F91-4754-4EE7-82F5-8D356792415B

P356

CDLI.12.3.387-398.2005

P1433

Clinical and Vaccine Immunology

P1476

Comparison of antibody reperto ...... in acutely infected patients.

@en

P2093

Agnieszka Dryla

http://www.w3.org/2001/XMLSchema#string

Andreas Meinke

http://www.w3.org/2001/XMLSchema#string

Béla Kocsis

http://www.w3.org/2001/XMLSchema#string

Dieter Gelbmann

http://www.w3.org/2001/XMLSchema#string

Edith Bettinger

http://www.w3.org/2001/XMLSchema#string

Eszter Nagy

http://www.w3.org/2001/XMLSchema#string

Markus Hanner

http://www.w3.org/2001/XMLSchema#string

Sonja Prustomersky

http://www.w3.org/2001/XMLSchema#string

Tamás Henics

http://www.w3.org/2001/XMLSchema#string

Tamás Kustos

http://www.w3.org/2001/XMLSchema#string

P2860

Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal Toxin

Antimicrobial resistance: the example of Staphylococcus aureus

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002.

Identification of enolase as a laminin-binding protein on the surface of Staphylococcus aureus.

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

Identification of a Staphylococcus aureus extracellular matrix-binding protein with broad specificity.

Antibody response to fibronectin-binding adhesin FnbpA in patients with Staphylococcus aureus infections.

Extracellular-matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections.

Cloning and expression of the gene for a fibronectin-binding protein from Staphylococcus aureus.

Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus.

P304

387-398

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CDLI.12.3.387-398.2005

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15753252

http://www.w3.org/2001/XMLSchema#string

P921

P932

1065207

http://www.w3.org/2001/XMLSchema#string